Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder
The DOI matches its Crossref record.
Abstract
BACKGROUND: Bipolar disorder is among the 10 most disabling medical conditions worldwide. While lithium has been used extensively for bipolar disorder since the 1970s, second-generation antipsychotics (SGAs) have supplanted lithium since 1998. To date, no randomized comparative-effectiveness study has compared lithium and any SGA. METHOD: Within the duration of the study (September 2010-September 2013), participants with bipolar I or II disorder (DSM-IV-TR) were randomized for 6 months to receive lithium (n = 240) or quetiapine (n = 242). Lithium and quetiapine were combined with other medications for bipolar disorder consistent with typical clinical practice (adjunctive personalized treatment [APT], excluding any SGA for the lithium + APT group and excluding lithium or any other SGA for the quetiapine + APT group). Coprimary outcome measures included Clinical Global Impressions-Efficacy Index (CGI-EI) and necessary clinical adjustments, which measured number of changes in adjunctive personalized treatment. Secondary measures included a full range of symptoms, cardiovascular risk, functioning, quality of life, suicidal ideation and behavior, and adverse events. RESULTS: Participants improved across all measures, and over 20% had a sustained response. Primary (CGI-EI, P = .59; necessary clinical adjustments, P = .15) and secondary outcome changes were not statistically significantly different between the 2 groups. For participants with greater manic/hypomanic symptoms, CGI-EI changes were significantly more favorable with quetiapine + APT (P = .02). Among those with anxiety, the lithium + APT group had fewer necessary clinical adjustments per month (P = .02). Lithium was better tolerated than quetiapine in terms of the burden of side effects frequency (P = .05), intensity (P = .01), and impairment (P = .01). CONCLUSIONS: Despite adequate power to detect clinically meaningful differences, we found outcomes with lithium + APT and quetiapine + APT were not significantly different across 6 months of treatment for bipolar disorder. TRIAL REGISTRATION: ClinicalTrials.gov identifier for the Bipolar CHOICE study: NCT01331304.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Results were not presented separately for BDII, but BDII patients responded better to both treatments than did BDI patients.”
In the citing paper
“Adjunctive quetiapine was also studied in a 6‐month single‐blind trial which randomly assigned patients with either BDI or BDII to lithium or quetiapine added to treatment as usual. They were equally effective in preventing relapse.453”
In the citing paper
“As noted above, lithium was as effective as quetiapine in preventing relapse in a 6‐month single‐blind trial.453”
Citations
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
“An expert review of the available evidence for treatments of bipolar II disorder (BDII) and recommendations based on those findings are presented in Section 6.”
BackgroundInfluentialSelf-citationVieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.8 · Cited by 891
Self-citationCarvalho, A. F., Firth, J., & Vieta, E. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1906193 · Cited by 562
Rhee, T. G., Olfson, M., Nierenberg, A. A., & Wilkinson, S. T. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.19091000 · Cited by 244
Self-citationStaging in bipolar disorder: from theoretical framework to clinical utility
Berk, M., Post, R., Ratheesh, A., Gliddon, E., Singh, A., Vieta, E., Carvalho, A. F., Ashton, M. M., Berk, L., Cotton, S. M., et al. (2017) · World Psychiatry · doi:10.1002/wps.20441 · Cited by 216
Prediction of lithium response using clinical data
Nunes, A., Ardau, R., Berghöfer, A., Bocchetta, A., Chillotti, C., Deiana, V., Garnham, J. S., Grof, E., Hájek, T., Manchia, M., et al. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13122 · Cited by 95
Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?
Sani, G., Perugi, G., & Tondo, L. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0531-2 · Cited by 75
Morbidity in depressive disorders
Baldessarini, R. J., Forte, A., Selle, V., Sim, K., Tondo, L., Undurraga, J., & Vázquez, G. H. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448661 · Cited by 63
Challenging the Negative Perception of Lithium and Optimizing Its Long-Term Administration
RYBAKOWSKI, J. K. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00349 · Cited by 69
Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder
McElroy, S. L., Kemp, D. E., Friedman, E. S., Reilly‐Harrington, N. A., Sylvia, L. G., Calabrese, J. R., Rabideau, D. J., Ketter, T. A., Thase, M. E., Singh, V., et al. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12460 · Cited by 60
Self-citationTreatment of bipolar disorder: Review of evidence regarding quetiapine and lithium
Ketter, T. A., Miller, S., Dell’Osso, B. M., & Wang, P. W. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.11.002 · Cited by 62
Self-citationKupka, R., Duffy, A. C., Scott, J. L., Almeida, J., Balanzá‐Martínez, V., Birmaher, B. B., Bond, D. J., Brietzke, E. M., Chendo, I., Frey, B. N., et al. (2021) · Bipolar Disorders · doi:10.1111/bdi.13105 · Cited by 57
Self-citationLähteenvuo, M., Paljärvi, T., Tanskanen, A. J., Taipale, H. T., & Tiihonen, J. (2023) · The British Journal of Psychiatry · doi:10.1192/bjp.2023.75 · Cited by 47
Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors
Fung, V., Overhage, L., Sylvia, L. G., Reilly-Harrington, N. A., Kamali, M., Gao, K., Shelton, R. C., Ketter, T. A., Bobo, W. V., Thase, M. E., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.06.050 · Cited by 51
Self-citationUpdate on bipolar disorder biomarker candidates
Teixeira, A. L., Salem, H., Frey, B. N., Barbosa, I. G., & Machado‐Vieira, R. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1248413 · Cited by 50
Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship
Kamali, M., Reilly-Harrington, N. A., Chang, W. C., McInnis, M. G., McElroy, S. L., Ketter, T. A., Shelton, R. C., Deckersbach, T., Tohen, M. F., Kocsis, J. H., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.08.032 · Cited by 47
Self-citationSeverus, E., Bauer, M., & Geddes, J. R. (2018) · Pharmacopsychiatry · doi:10.1055/a-0627-7489 · Cited by 46
Amare, A. T., Thalamuthu, A., Schubert, K. O., Fullerton, J. M., Ahmed, M. B., Hartmann, S., Papiol, S., Heilbronner, U., Degenhardt, F., Ayele, F. T., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02149-1 · Cited by 44
Ferensztajn‐Rochowiak, E., Chłopocka-Woźniak, M., & RYBAKOWSKI, J. K. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-1111 · Cited by 45
Bipolar II disorder: a state‐of‐the‐art review
Berk, M., Corrales, A., Trisno, R., Dodd, S., Yatham, L. N., Vieta, E., McIntyre, R. S., Suppes, T. M., & Agustini, B. (2025) · World Psychiatry · doi:10.1002/wps.21300 · Cited by 51
Sylvia, L. G., Chang, W. C., Kamali, M., Tohen, M. F., Kinrys, G., Deckersbach, T., Calabrese, J. R., Thase, M. E., Reilly-Harrington, N. A., Bobo, W. V., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.056 · Cited by 33
Self-citationCarli, M., Weiss, F., Grenno, G., Ponzini, S., Kolachalam, S., Vaglini, F., Viaggi, C., Pardini, C., Tidona, S., Longoni, B., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230224102318 · Cited by 42
Wingård, L., Brandt, L., Bodén, R., Kieler, H., Andersen, M. T., & Reutfors, J. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.04.003 · Cited by 27
Chia, M. F., Cotton, S., Filia, K., Phelan, M., Conus, P., Jauhar, S., Marwaha, S., McGorry, P. D., Davey, C. G., Berk, M., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.062 · Cited by 34
Predictive modeling for response to lithium and quetiapine in bipolar disorder
Kim, T. T., Dufour, S. C., Xu, C., Cohen, Z. D., Sylvia, L. G., Deckersbach, T., DeRubeis, R. J., & Nierenberg, A. A. (2019) · Bipolar Disorders · doi:10.1111/bdi.12752 · Cited by 25
Self-citationSampogna, G., Janiri, D., Albert, U., Caraci, F., Martinotti, G., Serafini, G., Tortorella, A. A. V., Zuddas, A., Sani, G., & Fiorillo, A. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2161895 · Cited by 28
Lithium, the gold standard drug for bipolar disorder: analysis of current clinical studies
Airainer, M., & Seifert, R. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03210-8 · Cited by 39
Saunders, E. F. H., Mukherjee, D., Myers, T. J., Wasserman, E. J., Hameed, A., Krishnamurthy, V. B., MacIntosh, B., Domenichiello, A. F., Ramsden, C. E., & Wang, M. (2021) · Bipolar Disorders · doi:10.1111/bdi.13112 · Cited by 27
Yaramala, S. R., McElroy, S. L., Geske, J. R., Winham, S. J., Gao, K., Reilly-Harrington, N. A., Ketter, T. A., Deckersbach, T., Kinrys, G., Kamali, M., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.025 · Cited by 23
Self-citationLithium treatment – the state of the art for 2020
RYBAKOWSKI, J. K. (2020) · Psychiatria Polska · doi:10.12740/pp/128340 · Cited by 29
Clinical correlates of acute bipolar depressive episode with psychosis
Caldieraro, M. A., Sylvia, L. G., Dufour, S. C., Walsh, S. L., JANOS, J. A., Rabideau, D. J., Kamali, M., McInnis, M. G., Bobo, W. V., Friedman, E. S., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.059 · Cited by 19
Self-citationCan lithium salts prevent depressive episodes in the real world?
González-Pinto, A. M., López-Peña, P., Ampudia, C. B., Vieta, E., & Martínez‐Cengotitabengoa, M. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.09.008 · Cited by 19
Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale
Kinrys, G., Bowden, C. L., Nierenberg, A. A., Hearing, C. M., Gold, A. K., Rabideau, D. J., Sylvia, L. G., Gao, K., Kamali, M., Bobo, W. V., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.039 · Cited by 20
Self-citationGao, K., Goto, T., Yuan, C., Brownrigg, B., Conroy, C. M., Chan, P. K., Serrano, M. B., Ganocy, S. J., Fang, F., & Calabrese, J. R. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000927 · Cited by 18
Self-citationAdvances in the psychopharmacotherapy of bipolar disorder type I
Sleem, A., & El‐Mallakh, R. S. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1893306 · Cited by 16
Kuperberg, M., Köhler‐Forsberg, O., Shannon, A. P., George, N., Greenebaum, S. L. A., Bowden, C. L., Calabrese, J. R., Thase, M. E., Shelton, R. C., McInnis, M. G., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.047 · Cited by 19
Self-citationMcWilliams, N. (2016) · Journal of Psychotherapy Integration · doi:10.1037/int0000054 · Cited by 17
Treatment outcomes of acute bipolar depressive episode with psychosis
Caldieraro, M. A., Dufour, S. C., Sylvia, L. G., Gao, K., Ketter, T. A., Bobo, W. V., Walsh, S. L., JANOS, J. A., Tohen, M. F., Reilly-Harrington, N. A., et al. (2018) · Depression and Anxiety · doi:10.1002/da.22716 · Cited by 15
Self-citationKöhler‐Forsberg, O., Sylvia, L. G., Thase, M. E., Calabrese, J. R., Tohen, M. F., Bowden, C. L., McInnis, M. G., Iosifescu, D. V., Kocsis, J. H., Friedman, E. S., et al. (2022) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674221077619 · Cited by 14
Self-citationKamali, M., Pegg, S. L., JANOS, J. A., Bobo, W. V., Brody, B. D., Gao, K., Ketter, T. A., McElroy, S. L., McInnis, M. G., Rabideau, D. J., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.05.082 · Cited by 11
Self-citationBehrendt-Møller, I., Madsen, T., Sørensen, H. J., Sylvia, L. G., Friedman, E. S., Shelton, R. C., Bowden, C. L., Calabrese, J. R., McElroy, S. L., Ketter, T. A., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12715 · Cited by 12
Self-citationAn evaluation of suicidal risk in bipolar patients with comorbid posttraumatic stress disorder
Katz, D., Petersen, T., Amado, S., Kuperberg, M., Dufour, S. C., Rakhilin, M., Hall, N. E., Kinrys, G., Desrosiers, A., Deckersbach, T., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.091 · Cited by 11
Self-citationWoo, Y. S., Jeong, J., Kang, H., Lee, K., Shim, S.-H., Kwon, Y., Lee, S.-Y., Jang, S.-H., Park, Y., Jon, D., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.257 · Cited by 10
Aaronson, S. T., Sackeïm, H. A., Jiang, M., Badejo, S., Greco, T., Bunker, M. T., Conway, C. R., Demyttenaere, K., Young, A. H., McAllister-Williams, H., et al. (2023) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674231209837 · Cited by 10
Psychotic symptoms during bipolar depressive episodes and suicidal ideation
Kuperberg, M., Katz, D., Greenebaum, S. L. A., George, N., Sylvia, L. G., Kinrys, G., Desrosiers, A., & Nierenberg, A. A. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.184 · Cited by 11
Self-citationUpdated perspectives on how and when lithium should be used in the treatment of mood disorders
RYBAKOWSKI, J. K., & Ferensztajn‐Rochowiak, E. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2181076 · Cited by 14
Cloete, K. J., Jenčič, B., Šmit, Ž., Kelemen, M., Mkentane, K., & Pelicon, P. (2017) · Analytical Methods · doi:10.1039/c7ay01616f · Cited by 9
Gao, K., Arnold, J. G., Prihoda, T. J., Quinones, M. P., Singh, V. K., Schinagle, M., Conroy, C. M., D’Arcangelo, N., Bai, Y., Calabrese, J. R., et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4604 · Cited by 10
Self-citationKöhler‐Forsberg, O., Sloth, K. H., Sylvia, L. G., Thase, M. E., Calabrese, J. R., Tohen, M. F., Bowden, C. L., McInnis, M. G., Kocsis, J. H., Friedman, E. S., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114194 · Cited by 9
Self-citationReilly-Harrington, N. A., Sylvia, L. G., Rabideau, D. J., Gold, A. K., Deckersbach, T., Bowden, C. L., Bobo, W. V., Singh, V. K., Calabrese, J. R., Shelton, R. C., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.07.007 · Cited by 8
Self-citationKöhler‐Forsberg, O., Sylvia, L. G., Fung, V., Overhage, L., Thase, M. E., Calabrese, J. R., Deckersbach, T., Tohen, M. F., Bowden, C. L., McInnis, M. G., et al. (2020) · Depression and Anxiety · doi:10.1002/da.23069 · Cited by 10
Self-citationPharmacologic treatment and management of bipolar disorder in adolescents
Elsayed, O. H., Pahwa, M., & El‐Mallakh, R. S. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2083954 · Cited by 11
Hodgkin, D., Stewart, M. T., Merrick, E. L., Pogue, Y. Z., Reilly-Harrington, N. A., Sylvia, L. G., Deckersbach, T., & Nierenberg, A. A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.012 · Cited by 6
Self-citationTreatment of Acute and Maintenance Phase of Bipolar Depression
Erten, E. (2021) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.27408 · Cited by 9
Spelber, D., Almeida, J., & Nemeroff, C. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00019-0 · Cited by 5
Treatment Guidelines in Bipolar Disorders and the Importance of Proper Clinical Trial Design
Tohen, M. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx002 · Cited by 5
Self-citationCaldieraro, M. A., Walsh, S. L., Deckersbach, T., Bobo, W. V., Gao, K., Ketter, T. A., Shelton, R. C., Reilly-Harrington, N. A., Tohen, M. F., Calabrese, J. R., et al. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417741982 · Cited by 4
Self-citationBipolar disorder: The foundational role of mood stabilizers
Shah, B. (2023) · Current Psychiatry · doi:10.12788/cp.0346 · Cited by 3
Wrobel, A. L., Turner, M., Dean, O. M., Berk, M., Sylvia, L. G., Thase, M. E., Deckersbach, T., Tohen, M. F., McInnis, M. G., Kocsis, J. H., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116197 · Cited by 3
Self-citationUpdate – Lithium in der Phasenprophylaxe Bipolarer Störungen
Petzold, J., Bauer, M., & Severus, E. (2018) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-0633-2511 · Cited by 2
Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics)
Uchida, H., Kim, E., Jarskog, L. F., Fleischhacker, W. W., Remington, G. J., & Lieberman, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_134-1 · Cited by 2
Pharmacological Treatment of Bipolar Disorder in the Elderly
Katz, T. C., Georgakas, J. E., Motyl, C. M., Quayle, W., & Forester, B. P. (2017) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0101-5 · Cited by 2
Sarani, E. M., Etemad, S. Z., & Dehbozorgi, R. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08084-z · Cited by 1
Robertson, L. J., Miot, J., & van Rensburg, B. J. (2017) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v23i0.1057 · Cited by 1
Wang, B.-Z., Deng, B., Su, S., Ding, S., & Sun, W. (2018) · Journal of Electronic Materials · doi:10.1007/s11664-018-6494-0 · Cited by 1
Lithium and Its Role in Psychiatry
Kamali, M., Ostacher, M. J., & Perlis, R. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11844-9.00053-9 · Cited by 1
Self-citationDiagnostik und Therapie bipolarer Störungen
Beier, F., Severus, E., & Bauer, M. (2020) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-020-1516-x · Cited by 1
A Brief Commentary on the Bipolar CHOICE Study
Suppes, T. M. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15com10105
‘Mood stabilizers’ as the royal road to nirvana or a narrow bridge to well-being?
Nierenberg, A. A. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417711272
Self-citationLithium in der Langzeittherapie der bipolaren Störung — was gibt es Neues?
Petzold, J., Bauer, M., & Severus, E. (2017) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-017-1742-3
Parise, V. F., Addeo, L., Laezza, R., Benedetto, R. D., Vivo, E. D., & Bianco, P. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.11.526
Guidelines on Mood Stabilizers
Gfesser, J., & Kittel‐Schneider, S. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_117-1
Guidelines on Mood Stabilizers
Gfesser, J., & Kittel‐Schneider, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_117
Missio, G., Santos, C. R. G. R. D., Moreira, M. A. M., Pimentel, F. C., Fernandes, F. D. S., Demétrio, F. N., Moreno, D. H., Matos, F. M., & Moreno, R. A. (2023) · Research Square · doi:10.21203/rs.3.rs-2484630/v1
Medications for Bipolar Disorder
Mitchell, P. B. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_135-1
Almeida, J., Spelber, D., & Smith, T. L. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as37 · Cited by 2
(2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551289.cd05
Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics)
Uchida, H., Kim, E., Jarskog, L. F., Fleischhacker, W. W., Remington, G. J., & Lieberman, J. A. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_134 · Cited by 1
Medications for Bipolar Disorder
Mitchell, P. B. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_135 · Cited by 1
Lithium and Its Role in Psychiatry
Kamali, M., Ostacher, M. J., & Perlis, R. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11972-9.00004-1
Self-citationBipolar disorder measurement-based care: Two-phase trial in primary care
Cerimele, J. M., Blanchard, B. E., Leasure, W. B., Park, J. H., Chase, E., & Fortney, J. C. (2026) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2026.04.010
Metadata
- Authors
- Nierenberg, A. A., McElroy, S. L., Friedman, E. S., Ketter, T. A., Shelton, R. C., Deckersbach, T., McInnis, M. G., Bowden, C. L., Tohen, M., Kocsis, J. H., Calabrese, J. R., Kinrys, G., Bobo, W. V., Singh, V., Kamali, M., Kemp, D., Brody, B., Reilly-Harrington, N. A., Sylvia, L. G., Shesler, L. W., Bernstein, E. E., Schoenfeld, D., Rabideau, D. J., Leon, A. C., Faraone, S., & Thase, M. E.
- Affiliations
- Harvard University (US)
- University of Cincinnati (US)
- University of Pittsburgh (US)
- Stanford University (US)
- University of Alabama at Birmingham (US)
- University of Michigan (US)
- The University of Texas at Austin (US)
- University of New Mexico (US)
- Cornell University (US)
- Case Western Reserve University (US)
- Mayo Clinic (US)
- SUNY Upstate Medical University (US)
- University of Pennsylvania (US)
- ORCID
- Nierenberg, Andrew A.
- McElroy, Susan L.
- Ketter, Terence A.
- Shelton, Richard C.
- Deckersbach, Thilo
- McInnis, Melvin G.
- Tohen, Mauricio
- Calabrese, Joseph R.
- Kinrys, Gustavo
- Bobo, William V.
- Singh, Vivek
- Kamali, Masoud
- Kemp, David
- Brody, Benjamin
- Reilly-Harrington, Noreen A.
- Sylvia, Louisa G.
- Bernstein, Emily E.
- Schoenfeld, David
- Rabideau, Dustin J.
- Leon, Andrew C.
- Faraone, Stephen
- Thase, Michael E.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2016-01-27
- Volume
- 77
- Issue
- 01
- Pages
- 90-99
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2278240795
- Cited by
- 81
- References
- 0
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 9 · 2023: 9 · 2022: 4 · 2021: 8 · 2020: 9 · 2019: 7 · 2018: 13 · 2017: 12 · 2016: 4
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agency for Healthcare Research and Quality (R01HS019371, 1R01HS019371)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- bipolar disorder, lithium, quetiapine, atypical antipsychotics, comparative effectiveness, anxiety, drug tolerability, adverse effects, suicidal ideation, quality of life, cardiovascular risk
- MeSH terms
- Quetiapine Fumarate, Adult, Bipolar Disorder, Female, Humans, Lithium, Male, Middle Aged, Antipsychotic Agents, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.